Sugammadex Piramal Uniunea Europeană - română - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - blocaj blocant - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Uniunea Europeană - română - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Uniunea Europeană - română - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Adroiq Uniunea Europeană - română - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

CANDESARTAN HCT SWYSSI 16 mg/12,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

candesartan hct swyssi 16 mg/12,5 mg

swyssi ag - germania - combinatii (candesartanum cilexetil+hct) - compr. - 16mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

CANDESARTAN HCT SWYSSI 8 mg/12,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

candesartan hct swyssi 8 mg/12,5 mg

swyssi ag - germania - combinatii (candesartanum cilexetil+hct) - compr. - 8mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

PEMETREXED SEACROSS 100 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pemetrexed seacross 100 mg

seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 100mg - antimetaboliti analogi ai acidului folic

PEMETREXED SEACROSS 500 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pemetrexed seacross 500 mg

seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500mg - antimetaboliti analogi ai acidului folic